The global central nervous system (CNS) therapeutics market, valued at USD 123.39 billion in 2024, is projected to grow at a CAGR of 7.6% from 2025 to 2034. This expansion trajectory underscores the deepening demand for effective CNS treatment options amid a complex regional landscape defined by uneven healthcare infrastructure, regulatory disparities, and technological maturity. In particular,...